Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Vav3 | Rat | 1,2-dichloroethane | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of VAV3 mRNA | CTD | PMID:28960355 | Vav3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of VAV3 mRNA | CTD | PMID:22206623 | Vav3 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | VAV3 (Homo sapiens) | 6480464 | Ethinyl Estradiol affects the expression of VAV3 mRNA | CTD | PMID:26865667 | Vav3 | Rat | 17beta-estradiol | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of VAV3 mRNA; [Estradiol co-treated with TGFB1 more ... | CTD | PMID:19619570|PMID:30165855 | Vav3 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VAV3 mRNA | CTD | PMID:32741896 | Vav3 | Rat | 17beta-estradiol | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of VAV3 mRNA | CTD | PMID:31614463|PMID:32234386|PMID:32387340 | Vav3 | Rat | 17beta-estradiol | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of VAV3 mRNA | CTD | PMID:19619570 | Vav3 | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VAV3 mRNA | CTD | PMID:32741896 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of VAV3 mRNA | CTD | PMID:19619570 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VAV3 mRNA | CTD | PMID:34747641 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAV3 mRNA | CTD | PMID:32109520|PMID:33387578 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAV3 mRNA | CTD | PMID:20106945|PMID:21632981|PMID:26238291 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VAV3 mRNA | CTD | PMID:19933214 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VAV3 mRNA | CTD | PMID:19619570 | Vav3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAV3 mRNA | CTD | PMID:19465110 | Vav3 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of VAV3 mRNA | CTD | PMID:32109520 | Vav3 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VAV3 mRNA | CTD | PMID:30071829 | Vav3 | Rat | 3-methylcholanthrene | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of VAV3 mRNA | CTD | PMID:20713471 | Vav3 | Rat | 5-fluorouracil | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of VAV3 mRNA | CTD | PMID:16557594 | Vav3 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of VAV3 mRNA | CTD | PMID:24780913 | Vav3 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of VAV3 mRNA | CTD | PMID:31881176 | Vav3 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of VAV3 mRNA | CTD | PMID:28959563 | Vav3 | Rat | aflatoxin B1 | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of VAV3 mRNA | CTD | PMID:22100608 | Vav3 | Rat | aflatoxin B1 | increases methylation | ISO | VAV3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of VAV3 intron | CTD | PMID:30157460 | Vav3 | Rat | aflatoxin B1 | decreases methylation | ISO | VAV3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of VAV3 gene | CTD | PMID:27153756 | Vav3 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of VAV3 mRNA | CTD | PMID:23630614 | Vav3 | Rat | all-trans-retinoic acid | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of VAV3 mRNA | CTD | PMID:21934132|PMID:23724009|PMID:33167477 | Vav3 | Rat | amphotericin B | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Amphotericin B analog results in decreased expression of VAV3 mRNA; Amphotericin B results in decreased more ... | CTD | PMID:28534445 | Vav3 | Rat | antimycin A | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of VAV3 mRNA | CTD | PMID:33512557 | Vav3 | Rat | antirheumatic drug | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of VAV3 mRNA | CTD | PMID:24449571 | Vav3 | Rat | aristolochic acid A | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of VAV3 mRNA | CTD | PMID:33212167 | Vav3 | Rat | arsane | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VAV3 more ... | CTD | PMID:32525701 | Vav3 | Rat | arsane | affects methylation | ISO | VAV3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of VAV3 gene | CTD | PMID:25304211 | Vav3 | Rat | arsenic atom | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VAV3 more ... | CTD | PMID:32525701 | Vav3 | Rat | arsenic atom | affects methylation | ISO | VAV3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of VAV3 gene | CTD | PMID:25304211 | Vav3 | Rat | arsenous acid | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of VAV3 mRNA | CTD | PMID:20458559 | Vav3 | Rat | Azoxymethane | multiple interactions | ISO | Vav3 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VAV3 more ... | CTD | PMID:29950665 | Vav3 | Rat | benzo[a]pyrene | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of VAV3 mRNA | CTD | PMID:20713471 | Vav3 | Rat | benzo[a]pyrene | increases methylation | ISO | VAV3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of VAV3 exon | CTD | PMID:27901495 | Vav3 | Rat | benzo[a]pyrene | affects methylation | ISO | VAV3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of VAV3 promoter | CTD | PMID:27901495 | Vav3 | Rat | benzo[a]pyrene | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of VAV3 mRNA | CTD | PMID:20064835|PMID:21632981|PMID:22316170|PMID:26238291 | Vav3 | Rat | benzo[a]pyrene | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Benzo(a)pyrene metabolite results in increased expression of VAV3 mRNA | CTD | PMID:26314263 | Vav3 | Rat | benzo[a]pyrene | affects expression | ISO | Vav3 (Mus musculus) | 6480464 | Benzo(a)pyrene affects the expression of VAV3 mRNA | CTD | PMID:21569818 | Vav3 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of VAV3 mRNA | CTD | PMID:26238291 | Vav3 | Rat | benzo[b]fluoranthene | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of VAV3 mRNA | CTD | PMID:26377693 | Vav3 | Rat | Benzo[k]fluoranthene | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | benzo(k)fluoranthene results in decreased expression of VAV3 mRNA | CTD | PMID:21635667 | Vav3 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of VAV3 mRNA | CTD | PMID:25181051 | Vav3 | Rat | bisphenol A | increases methylation | ISO | VAV3 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of VAV3 gene | CTD | PMID:31601247 | Vav3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of VAV3 mRNA | CTD | PMID:30816183|PMID:34947998 | Vav3 | Rat | bisphenol A | affects expression | ISO | VAV3 (Homo sapiens) | 6480464 | bisphenol A affects the expression of VAV3 mRNA | CTD | PMID:30903817 | Vav3 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of VAV3 gene | CTD | PMID:28505145 | Vav3 | Rat | butanal | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of VAV3 mRNA | CTD | PMID:26079696 | Vav3 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VAV3 more ... | CTD | PMID:39012411 | Vav3 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VAV3 more ... | CTD | PMID:39012411 | Vav3 | Rat | cadmium dichloride | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of VAV3 mRNA | CTD | PMID:38174414 | Vav3 | Rat | calcitriol | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of VAV3 mRNA | CTD | PMID:16002434 | Vav3 | Rat | carbon nanotube | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | Nanotubes, Carbon results in increased expression of VAV3 mRNA | CTD | PMID:25554681 | Vav3 | Rat | chloroprene | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | Chloroprene results in increased expression of VAV3 mRNA | CTD | PMID:23125180 | Vav3 | Rat | chlorpyrifos | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of VAV3 mRNA | CTD | PMID:37019170 | Vav3 | Rat | chromium(6+) | affects expression | ISO | Vav3 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of VAV3 mRNA | CTD | PMID:28472532 | Vav3 | Rat | cisplatin | affects response to substance | ISO | VAV3 (Homo sapiens) | 6480464 | VAV3 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | Vav3 | Rat | cobalt dichloride | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of VAV3 mRNA | CTD | PMID:26314263 | Vav3 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of VAV3 mRNA | CTD | PMID:30556269 | Vav3 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of VAV3 mRNA | CTD | PMID:30556269 | Vav3 | Rat | copper(II) chloride | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of VAV3 mRNA | CTD | PMID:38568856 | Vav3 | Rat | copper(II) sulfate | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of VAV3 mRNA | CTD | PMID:19549813 | Vav3 | Rat | cordycepin | affects expression | ISO | VAV3 (Homo sapiens) | 6480464 | cordycepin affects the expression of VAV3 mRNA | CTD | PMID:28099944 | Vav3 | Rat | crocidolite asbestos | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in decreased expression of VAV3 mRNA | CTD | PMID:18687144|PMID:25351596 | Vav3 | Rat | cyclosporin A | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of VAV3 mRNA | CTD | PMID:21632981|PMID:25562108 | Vav3 | Rat | DDE | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of VAV3 mRNA | CTD | PMID:38568856 | Vav3 | Rat | dextran sulfate | multiple interactions | ISO | Vav3 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VAV3 more ... | CTD | PMID:29950665 | Vav3 | Rat | diarsenic trioxide | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of VAV3 mRNA | CTD | PMID:20458559 | Vav3 | Rat | dioxygen | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of VAV3 mRNA | CTD | PMID:26516004 | Vav3 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of VAV3 mRNA | CTD | PMID:21551480 | Vav3 | Rat | dorsomorphin | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Vav3 | Rat | doxorubicin | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of VAV3 mRNA | CTD | PMID:39631538 | Vav3 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of VAV3 mRNA | CTD | PMID:23962444 | Vav3 | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of VAV3 mRNA | CTD | PMID:34044035 | Vav3 | Rat | genistein | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Genistein results in decreased expression of VAV3 mRNA | CTD | PMID:26865667 | Vav3 | Rat | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of VAV3 mRNA | CTD | PMID:24915197 | Vav3 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of VAV3 gene | CTD | PMID:35440735 | Vav3 | Rat | GSK-J4 | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | GSK-J4 results in increased expression of VAV3 mRNA | CTD | PMID:29301935 | Vav3 | Rat | Indeno[1,2,3-cd]pyrene | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | indeno(1,2,3-cd)pyrene results in decreased expression of VAV3 mRNA | CTD | PMID:21635667 | Vav3 | Rat | lead diacetate | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | lead acetate results in decreased expression of VAV3 mRNA | CTD | PMID:38568856 | Vav3 | Rat | leflunomide | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of VAV3 mRNA | CTD | PMID:28988120 | Vav3 | Rat | luteolin | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Luteolin results in decreased expression of VAV3 mRNA | CTD | PMID:19397994 | Vav3 | Rat | methotrexate | affects expression | ISO | Vav3 (Mus musculus) | 6480464 | Methotrexate affects the expression of VAV3 mRNA | CTD | PMID:18502557 | Vav3 | Rat | methotrexate | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of VAV3 mRNA | CTD | PMID:17400583 | Vav3 | Rat | methylmercury chloride | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of VAV3 mRNA | CTD | PMID:28001369 | Vav3 | Rat | methylmercury(1+) | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | methylmercury II results in increased expression of VAV3 mRNA | CTD | PMID:26314263 | Vav3 | Rat | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of VAV3 mRNA | CTD | PMID:28801915 | Vav3 | Rat | nickel atom | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of VAV3 mRNA | CTD | PMID:25583101 | Vav3 | Rat | ochratoxin A | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | ochratoxin A metabolite results in increased expression of VAV3 mRNA; ochratoxin A results in increased more ... | CTD | PMID:26314263 | Vav3 | Rat | okadaic acid | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of VAV3 mRNA | CTD | PMID:38832940 | Vav3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of VAV3 mRNA | CTD | PMID:25729387 | Vav3 | Rat | ozone | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Ozone results in decreased expression of VAV3 mRNA | CTD | PMID:23033980 | Vav3 | Rat | ozone | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of VAV3 mRNA | CTD | PMID:35430440 | Vav3 | Rat | ozone | multiple interactions | ISO | Vav3 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:34911549 | Vav3 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of VAV3 mRNA | CTD | PMID:33387578 | Vav3 | Rat | Pf-06840003 | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | PF-06840003 inhibits the reaction [APAF1 protein mutant form results in increased expression of VAV3 mRNA]; more ... | CTD | PMID:39172838 | Vav3 | Rat | Pf-06840003 | multiple interactions | ISO | Vav3 (Mus musculus) | 6480464 | PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased more ... | CTD | PMID:39172838 | Vav3 | Rat | phenylmercury acetate | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of VAV3 mRNA | CTD | PMID:26272509 | Vav3 | Rat | phenylmercury acetate | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Vav3 | Rat | pirinixic acid | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of VAV3 mRNA | CTD | PMID:20813756 | Vav3 | Rat | pirinixic acid | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of VAV3 mRNA | CTD | PMID:17426115 | Vav3 | Rat | resveratrol | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | resveratrol results in decreased expression of VAV3 mRNA | CTD | PMID:19371625 | Vav3 | Rat | SB 431542 | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Vav3 | Rat | silicon dioxide | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of VAV3 mRNA; Silicon Dioxide results in decreased more ... | CTD | PMID:25351596|PMID:25895662 | Vav3 | Rat | silver atom | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Silver results in decreased expression of VAV3 mRNA | CTD | PMID:26014281 | Vav3 | Rat | silver(0) | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Silver results in decreased expression of VAV3 mRNA | CTD | PMID:26014281 | Vav3 | Rat | sodium arsenate | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VAV3 more ... | CTD | PMID:32525701 | Vav3 | Rat | sodium arsenate | increases expression | ISO | Vav3 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of VAV3 mRNA | CTD | PMID:21795629 | Vav3 | Rat | sodium arsenite | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of VAV3 mRNA | CTD | PMID:24516582|PMID:38568856|PMID:39719251 | Vav3 | Rat | sodium arsenite | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of VAV3 mRNA | CTD | PMID:37682722 | Vav3 | Rat | sodium arsenite | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of VAV3 mRNA | CTD | PMID:34032870 | Vav3 | Rat | sodium dichromate | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | sodium bichromate results in decreased expression of VAV3 mRNA | CTD | PMID:17685462 | Vav3 | Rat | succimer | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VAV3 mRNA | CTD | PMID:26378955 | Vav3 | Rat | tamibarotene | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of VAV3 mRNA | CTD | PMID:17229644 | Vav3 | Rat | temozolomide | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of VAV3 mRNA | CTD | PMID:31758290 | Vav3 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VAV3 mRNA | CTD | PMID:32741896 | Vav3 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of VAV3 mRNA | CTD | PMID:31150632 | Vav3 | Rat | tetraphene | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | benz(a)anthracene results in decreased expression of VAV3 mRNA | CTD | PMID:21635667 | Vav3 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of VAV3 mRNA | CTD | PMID:34492290 | Vav3 | Rat | thiram | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Thiram results in decreased expression of VAV3 mRNA | CTD | PMID:38568856 | Vav3 | Rat | titanium dioxide | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of VAV3 mRNA | CTD | PMID:29264374 | Vav3 | Rat | titanium dioxide | multiple interactions | ISO | Vav3 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VAV3 more ... | CTD | PMID:29950665 | Vav3 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of VAV3 mRNA | CTD | PMID:25729387 | Vav3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of VAV3 mRNA | CTD | PMID:25729387 | Vav3 | Rat | tributylstannane | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | tributyltin results in increased expression of VAV3 mRNA | CTD | PMID:26314263 | Vav3 | Rat | Tributyltin oxide | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of VAV3 mRNA | CTD | PMID:26314263 | Vav3 | Rat | trichostatin A | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of VAV3 mRNA | CTD | PMID:24935251 | Vav3 | Rat | triphenyl phosphate | decreases expression | EXP | | 6480464 | triphenyl phosphate results in decreased expression of VAV3 mRNA | CTD | PMID:30589522 | Vav3 | Rat | triptonide | decreases expression | ISO | Vav3 (Mus musculus) | 6480464 | triptonide results in decreased expression of VAV3 mRNA | CTD | PMID:33045310 | Vav3 | Rat | urethane | decreases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of VAV3 mRNA | CTD | PMID:28818685 | Vav3 | Rat | valproic acid | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of VAV3 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:27188386|PMID:28001369 | Vav3 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of VAV3 mRNA | CTD | PMID:23034163 | Vav3 | Rat | vorinostat | multiple interactions | ISO | VAV3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Vav3 | Rat | vorinostat | increases expression | ISO | VAV3 (Homo sapiens) | 6480464 | vorinostat results in increased expression of VAV3 mRNA | CTD | PMID:26272509 | |






















